Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 7/20 | 0.41 |
| ▸ | AKT2 | P31751 | 6/20 | 0.41 |
| ▸ | KIT | P10721 | 2/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | PDE2A | O00408 | 4/20 | 0.33 |
| ▸ | DRD2 | P14416 | 2/20 | 0.31 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.31 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34469676 | 0.96 | AKT1 (0.41) | AKT1AKT2KITCNR1CNR2 | |
| SCHEMBL34470005 | 0.93 | AKT1 (0.43) | AKT1AKT2KITCNR1CNR2 | |
| SCHEMBL34470019 | 0.92 | AKT1 (0.42) | AKT1AKT2KITCNR1CNR2 | |
| SCHEMBL34469468 | 0.89 | AKT1 (0.43) | AKT1AKT2KITCNR1CNR2 | |
| SCHEMBL34469946 | 0.88 | AKT1 (0.42) | AKT1AKT2KITCNR1CNR2 | |
| SCHEMBL34469566 | 0.86 | AKT1 (0.43) | AKT1AKT2KITCNR1CNR2 | |
| SCHEMBL34470144 | 0.82 | AKT1 (0.35) | AKT1AKT2PDE2A | |
| SCHEMBL34469923 | 0.82 | EGLN2 (0.33) | AKT1KITPKMPDE2A | |
| SCHEMBL34469978 | 0.82 | AKT1 (0.43) | AKT1AKT2KITCNR1CNR2 | |
| SCHEMBL34469987 | 0.81 | AKT1 (0.35) | AKT1PDE2AP2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026090477-A1 | HELICASE INHIBITORS AND USES THEREOF | KIMIA THERAPEUTICS, INC. (US) | 2026-04-30 | — | — | WO | disclosed |